The makers of Regeneron and Eli Lilly monoclonal antibody treatments have both said their treatments do not work against the omicron variant. NIH issued guidelines over a month ago saying to pull these treatments when omicron is >80% of infections. …es.covid19treatmentguidelines.nih.gov/guidelines/arc…
The makers of Regeneron and Eli Lilly monoclonal antibody treatments have both said their treatments do not work against the omicron variant. NIH issued guidelines over a month ago saying to pull these treatments when omicron is >80% of infections. …es.covid19treatmentguidelines.nih.gov/guidelines/arc…
@Daniel_Sweeney Hey @GovRonDeSantis this sure sounds like that “shred of evidence” you asked for…